• Department of Cardiothoracic Surgery, Yanda Hospital of Hebei Medical University, Langfang, 065201, Hebei, P. R. China;
WANG Wenzhang, Email: wwz9993@163.com
Export PDF Favorites Scan Get Citation

Objective To explore the surgical treatment of deep chest wall infection, improve the cure rate and reduce the recurrence rate.Methods The clinical data of 655 patients with deep chest wall infection treated in Yanda Hospital and Beijing Royal Integrative Medicine Hospital from June 2015 to June 2020 were retrospectively analyzed. There were 450 males and 205 females, aged 55.6±12.8 years. There were 8 patients with chest wall infection after tumor necrosis, 15 patients after radiotherapy and 632 patients after thoracotomy (612 patients after cardiovascular surgery and 20 patients after general thoracic surgery). Among them, 649 patients underwent debridement and reconstruction of chest wall defect with muscle flap.Results The average operation time was 95±65 min, the average intraoperative blood loss was 180±100 mL, and the average postoperative hospital stay was 13±6 d. Of the 649 patients who underwent muscle flap reconstruction after debridement, 597 patients recovered within 2 weeks, and the primary wound healing rate was 94.4%. Twenty-three (3.5%) patients died. The median follow-up time was 25 (2-40) months. Among the remaining 632 patients, 20 recurred, with a recurrence rate of 3.1% (20/632).Conclusion Pedicled muscle flap after thorough debridement of deep chest wall infection is one of the best methods to repair chest wall defect with pedicled muscle flap.

Citation: WANG Wenzhang, FENG Qing, YANG Shiyan, LIANG Zhuoru, CHENG Xiangyi, WANG Jing, LI Bowen, WANG Xiaofang, WANG Xiaohong. Surgical treatment of 655 patients with deep chest wall infection: A single-center retrospective analysis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(7): 904-908. doi: 10.7507/1007-4848.202012083 Copy

  • Previous Article

    Abnormally upregulated CNIH4 and TOMM40L genes may be associated with prognosis of hepatocellular carcinoma
  • Next Article

    Abnormally upregulated CNIH4 and TOMM40L genes may be associated with prognosis of hepatocellular carcinoma